Loading
Total declarations
Company
▲ Purchases (0 ops.)
▼ Sales (0 ops.)
Latest filing published 20 Nov 2023 for Acura Pharmaceuticals, INC.
Insider track record
Disclosed buys
0
Disclosed sells
0
Signal history
No signal scores available.
Robert B. Jones: trading record in brief
Robert B. Jones appears in our data through filings on Acura Pharmaceuticals, Inc shares, published by SEC (Form 4). Over a trading history stretching from 3 August 2022 to 20 November 2023, the count stands at 3 filings.
No open-market purchase or sale appears among the filings, only grants, plan transactions and other operations. Grants and option exercises follow pay plans set in advance, so they reveal less about an insider's own view than a purchase made with personal money.
The newest entry dates from 20 November 2023: an option exercise, in Acura Pharmaceuticals, Inc. Every figure here comes from the filings published by SEC (Form 4) and describes the past, not future prices; it is not investment advice.
Companies and markets linked to Robert B. Jones
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
Declarations3 total
40,000 sharesCommon StockSEC:0001104659-23-119813:0
50,000 sharesCommon StockSEC:0001104659-23-001412:0
63,666 sharesCommon StockSEC:0001104659-22-086713:0
3 of 3 declarations
